SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-010118
Filing Date
2022-05-16
Accepted
2022-05-16 16:43:33
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tern-20220331.htm   iXBRL 10-Q 2092920
2 EX-31.1 tern-ex31_1.htm EX-31.1 19568
3 EX-31.2 tern-ex31_2.htm EX-31.2 19569
4 EX-32.1 tern-ex32_1.htm EX-32.1 11729
5 EX-32.2 tern-ex32_2.htm EX-32.2 11736
6 GRAPHIC img254953215_0.jpg GRAPHIC 28447
  Complete submission text file 0000950170-22-010118.txt   9398588

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20220331_pre.xml EX-101.PRE 378124
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tern-20220331_def.xml EX-101.DEF 224151
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20220331.xsd EX-101.SCH 61105
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tern-20220331_cal.xml EX-101.CAL 54797
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20220331_lab.xml EX-101.LAB 516782
54 EXTRACTED XBRL INSTANCE DOCUMENT tern-20220331_htm.xml XML 2049922
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 22930187
SIC: 2834 Pharmaceutical Preparations